Andrew Hull serves as Executive at InMed Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Andrew Hull has executed 1 insider transactions totaling $14.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 21, 2024 involved purchasing 37,500 shares valued at $14.6K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 21, 2024 | INM | $14.6K | Purchase | 37,500 | $0.39 | Discretionary |
Andrew Hull currently holds 38,258 shares of InMed Pharmaceuticals Inc. (INM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Hull has been a net buyer of INM stock. They have purchased $14.6K and sold $0 worth of shares.
Andrew Hull's most recent insider trade was on Feb 21, 2024, when they purchased 37,500 shares at $0.39 per share.
Get notified when new Form 4 filings are submitted